Interleukin-10 impairs host defense in murine pneumococcal pneumonia

Journal of Infectious Diseases

Volumn 174, Issue 5, 1996, Pages 994-1000

  Van Der Poll, Tom ^b   Marchant, Arnaud ^b   Keogh, Christopher V ^b   Goldman, Michel ^b   Lowry, Stephen F ^a  

^a Department of Obstetrics Gynecology   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; TUMOR NECROSIS FACTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HOST RESISTANCE; IMMUNOMODULATION; IMMUNOREACTIVITY; LOBAR PNEUMONIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

EID: 0029958178     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.5.994     Document Type: Article

References (16)

1. Austrian R. Pneumococcal pneumonia. Diagnostic, epidemiologic, therapeutic and prophylactic considerations. Chest 1986;90:738-43.
2. American Thoracic Society. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 1993;148:1418-26.
3. Mufson MA. Streptococcus pneumoniae. In: Mandell GL, Bennet JE, Dolin R, eds. Principles and practice of infectious diseases. 3rd ed. New York: Churchill Livingstone, 1985:1539-50.
4. Klugman KP. Pneumococcal resistance to antibiotics. Clin Micobiol Rev 1990;3:171-96.
5. Friedland IR, McCracken GH. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med 1994;331:377-82.
6. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993;11:165-90.
7. De Waal Malefyt R, Abrams J, Bennett B, Figdor C, de Vries JE. IL-10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-20
8. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-22.
9. Cassatella MA, Meda L, Bonora S, Ceska M, Constantin G. Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1β in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 1993;178:2207-11.
10. Gérard C, Bruyns C, Marchant A, et al. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 1993;177:547-50.
11. Howard M, Muchamuel T, Andrade S, Menon S. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 1993;177:1205-8.
12. Marchant A, Bruyns C, Vandenabeele P, et al. IL-10 controls IFN-γ and TNF production during experimental endotoxemia. Eur J Immunol 1994;24:1167-71.
13. Bean AGD, Freiberg RA, Andrade S, Menon S, Zlotnik A. Interleukin 10 protects mice against staphylococcal enterotoxin B-induced lethal shock. Infect Immun 1993;61:4937-9.
14. Florquin S, Amraoui Z, Abramowicz D, Goldman M. Systemic release and protective role of IL-10 in staphylococcal enterotoxin B-induced shock in mice. J Immunol 1994;153:2618-23.
15. Kato T, Murata A, Toda H, et al. Interleukin 10 reduces mortality from severe peritonitis in mice. Antimicrob Agents Chemother 1995;39:1336-40.
16. Van der Poll T, Marchant A, Buurman WA, et al. Endogenous interleukin 10 protects mice from death during septic peritonitis. J Immunol 1995;155:5397-401.